2-(Tributylstannyl)pyridine → HCID 57634257, compound
Reaction equation
Br[C:2]1[O:6][C:5]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[CH:4][CH:3]=1.C([Sn](CCCC)(CCCC)[C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][N:26]=1)CCC>>[N:26]1[CH:27]=[CH:28][CH:29]=[CH:30][C:25]=1[C:2]1[O:6][C:5]([N:7]2[CH2:11][C@:10]3([CH:16]4[CH2:17][CH2:18][N:13]([CH2:14][CH2:15]4)[CH2:12]3)[O:9][C:8]2=[O:19])=[CH:4][CH:3]=1Participants
3
Procedure
The title compound was prepared by a method analogous to that described in Example 14 from (R)-3′-(5-bromofuran-2-yl)spiro[1-azabicyclo[2.2.2]octan-3,5′-oxazolidin]-2′-one and 2-(tri-n-butylstannyl)pyridine. The title compound (356 mg) was obtained as an off-white solid, m/z 326 (MH+).
Workup
- customThe title compound was prepared by a method analogous to
Sources & evidence
- ORD record
- ord-ac89b913f7ad4e9fa3f0b9d5430a516a
- Source dataset
- uspto-grants-2009_04
- Patent number
- US07514567B2
Reaction notes
Loading…